Lentiviral Gene Therapy for Epilepsy
Condition(s):Drug Resistant EpilepsyLast Updated:May 15, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Drug Resistant EpilepsyLast Updated:May 15, 2023Not yet recruiting
Condition(s):Transfusion-dependent Beta-Thalassemia; Gene TherapyLast Updated:August 14, 2023Recruiting
Condition(s):Non-small Cell Lung CancerLast Updated:February 9, 2024Recruiting
Condition(s):Gene TherapyLast Updated:March 27, 2020Recruiting
Condition(s):Cervical Intraepithelial Neoplasia; Cervical Neoplasms; Oropharyngeal Neoplasms; Squamous Intraepithelial Lesions of the Cervix; Hematologic MalignaciesLast Updated:March 13, 2024Enrolling by invitation
Condition(s):Alzheimer’s Disease; Mild Cognitive ImpairmentLast Updated:December 8, 2023Recruiting
Condition(s):Severe Combined Immunodeficiency Due to RAG1 DeficiencyLast Updated:March 17, 2023Recruiting
Condition(s):Glioblastoma Multiforme; Astrocytoma, Grade IIILast Updated:August 31, 2023Recruiting
Condition(s):HemophiliaLast Updated:May 12, 2021Not yet recruiting
Condition(s):Glioblastoma; Anaplastic AstrocytomaLast Updated:August 31, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.